Palantir’s stock played Wall Street whiplash today, diving nearly 5% before rebounding to finish up 2%. The plunge came after ...

Visa's Q2 performance exceeded expectations with net revenue of $9.59 billion, surpassing analyst estimates of $9.55 billion.

Berkshire Hathaway’s upcoming earnings report has Wall Street less curious about profit and more about what Warren Buffett ...

UnitedHealth Group's stock dipped 1.3% after Robert W. Baird lowered their price target from $640 to $510. The stock traded ...

Wills Financial Group Inc. upped its Chevron holdings by 4.9% last quarter, scooping up 1,867 more shares for a $5.8 million ...

Bank of America’s stock dipped a trivial 0.2% on Friday, but the analyst chatter surrounding it was anything but quiet.

AbbVie’s stock nudged up 0.7% after Guggenheim lifted its price target, joining a parade of bullish analyst upgrades. Several ...

Oxford Asset Management LLP gave Johnson & Johnson a healthy dose of confidence by raising its stake 257.8% in Q4, acquiring ...

Rothschild Capital Partners dropped nearly half a million dollars into Home Depot stock, purchasing 1,250 shares like it was ...

Merck is going all-in on domestic drug manufacturing with a $1 billion Delaware facility aimed at dodging Trump-era tariff ...

Broadcom’s stock took a 1.98% dip on April 28, 2025, after a promising start to the day. The stock opened strong, hitting ...

Representative Robert Bresnahan, Jr. sold shares of Eli Lilly and Company in April 2025, disclosing the transaction of $1,001 ...